Donald Siegel

23PUBLICATIONS
168CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Sep 13, 2026
Comparison of intestinal histopathological changes following teclistamab, BCMA-directed CAR T, CD19-directed CAR T and rituximab therapies.

|Aug 24, 2026
T-cell immunosenescence limits CD19 CAR T-cell function in chronic lymphocytic leukemia.

|Aug 10, 2026
Decade-long persistence of CD19 CAR T cells in B cell lymphomas.

|Jul 10, 2026
HIV-specific and resistant CAR T cells promote control of HIV replication in people with HIV.

|May 05, 2026
Rab5 improves CAR T cell efficacy via reducing fratricide and maintaining surface CAR levels.

|Mar 10, 2026
Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancer.

Gregory M Chen, Ankita Jain, David T Gering

Pageof 4

Frequent Collaborators

17 joint publications

Carl H June

11 joint publications

Elizabeth O Hexner

10 joint publications

Joseph Fraietta

10 joint publications

Bruce L Levine